<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>高血脂</title>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/semantic-ui/dist/semantic.min.css">
</head>
<body>
  <div class="ui grid">
    <div class="four wide column">
      <ul>
        
          <li>
            <h3>兒科</h3>
            <ul>
              
                <li><a href="/pages/0-0.html">腫瘤學</a></li>
              
                <li><a href="/pages/0-1.html">兒童發展、疫苗</a></li>
              
                <li><a href="/pages/0-2.html">新生兒呼吸相關疾病</a></li>
              
                <li><a href="/pages/0-3.html">小兒腎臟學疾病</a></li>
              
                <li><a href="/pages/0-4.html">新生兒感染感染</a></li>
              
                <li><a href="/pages/0-5.html">圖庫資源</a></li>
              
                <li><a href="/pages/0-6.html">新生兒科</a></li>
              
                <li><a href="/pages/0-7.html">新生兒黃疸(Neonatal Jaundice)</a></li>
              
                <li><a href="/pages/0-8.html">新生兒評估(Newborn PE)</a></li>
              
                <li><a href="/pages/0-9.html">遺傳學</a></li>
              
                <li><a href="/pages/0-10.html">血液學</a></li>
              
                <li><a href="/pages/0-11.html">兒童過敏免疫風濕疾病</a></li>
              
                <li><a href="/pages/0-12.html">內分泌疾病</a></li>
              
                <li><a href="/pages/0-13.html">神經系統性疾病</a></li>
              
                <li><a href="/pages/0-14.html">感染科學</a></li>
              
                <li><a href="/pages/0-15.html">消化系統</a></li>
              
                <li><a href="/pages/0-16.html">腦及神經疾病</a></li>
              
                <li><a href="/pages/0-17.html">血管性疾病</a></li>
              
                <li><a href="/pages/0-18.html">惡性腫瘤</a></li>
              
                <li><a href="/pages/0-19.html">生殖泌尿道</a></li>
              
                <li><a href="/pages/0-20.html">先天腹壁異常</a></li>
              
                <li><a href="/pages/0-21.html">肝膽道疾病</a></li>
              
                <li><a href="/pages/0-22.html">腸胃道</a></li>
              
                <li><a href="/pages/0-23.html">頸部腫塊[CS]</a></li>
              
                <li><a href="/pages/0-24.html">體液、電解質及營養</a></li>
              
                <li><a href="/pages/0-25.html">創傷</a></li>
              
                <li><a href="/pages/0-26.html">兒外</a></li>
              
                <li><a href="/pages/0-27.html">心臟肺部血管系統</a></li>
              
                <li><a href="/pages/0-28.html">兒科基礎</a></li>
              
                <li><a href="/pages/0-29.html">兒內</a></li>
              
                <li><a href="/pages/0-30.html">編輯格式</a></li>
              
            </ul>
          </li>
        
          <li>
            <h3>內科</h3>
            <ul>
              
                <li><a href="/pages/1-0.html">Mallory-Weiss Tear</a></li>
              
                <li><a href="/pages/1-1.html">胰臟腫瘤</a></li>
              
                <li><a href="/pages/1-2.html">慢性胰臟炎</a></li>
              
                <li><a href="/pages/1-3.html">胰臟疾病（Pancreas）-急性胰臟炎</a></li>
              
                <li><a href="/pages/1-4.html">PSC vs PBC</a></li>
              
                <li><a href="/pages/1-5.html">Cholangiocarcinoma</a></li>
              
                <li><a href="/pages/1-6.html">Cholangitis</a></li>
              
                <li><a href="/pages/1-7.html">Gallstone ileus</a></li>
              
                <li><a href="/pages/1-8.html">Cholecystitis</a></li>
              
                <li><a href="/pages/1-9.html">Cholelithiasis</a></li>
              
                <li><a href="/pages/1-10.html">膽道感染與腫瘤</a></li>
              
                <li><a href="/pages/1-11.html">膽道阻塞</a></li>
              
                <li><a href="/pages/1-12.html">膽道疾病-膽結石與膽囊炎</a></li>
              
                <li><a href="/pages/1-13.html">肝臟移植與TIPS</a></li>
              
                <li><a href="/pages/1-14.html">肝腫瘤與癌症</a></li>
              
                <li><a href="/pages/1-15.html">代謝性肝病</a></li>
              
                <li><a href="/pages/1-16.html">肝硬化與併發症</a></li>
              
                <li><a href="/pages/1-17.html">脂肪肝與酒精性肝病</a></li>
              
                <li><a href="/pages/1-18.html">急性與慢性肝炎</a></li>
              
                <li><a href="/pages/1-19.html">黃疸與膽紅素異常</a></li>
              
                <li><a href="/pages/1-20.html">肝臟疾病-肝功能異常與評估</a></li>
              
                <li><a href="/pages/1-21.html">Hemorrhoid </a></li>
              
                <li><a href="/pages/1-22.html">直腸肛門疾病</a></li>
              
                <li><a href="/pages/1-23.html">Colorectal Cancer</a></li>
              
                <li><a href="/pages/1-24.html">Ischemic Colitis</a></li>
              
                <li><a href="/pages/1-25.html">Diverticulitis</a></li>
              
                <li><a href="/pages/1-26.html">結腸疾病</a></li>
              
                <li><a href="/pages/1-27.html">腸躁症 IBS</a></li>
              
                <li><a href="/pages/1-28.html">Ulcerative Colitis</a></li>
              
                <li><a href="/pages/1-29.html">Crohn’s Disease</a></li>
              
                <li><a href="/pages/1-30.html">大腸與直腸疾病-IBD</a></li>
              
                <li><a href="/pages/1-31.html">Appendicitis</a></li>
              
                <li><a href="/pages/1-32.html">Peritonitis</a></li>
              
                <li><a href="/pages/1-33.html">急性腹症</a></li>
              
                <li><a href="/pages/1-34.html">小腸阻塞與功能障礙</a></li>
              
                <li><a href="/pages/1-35.html">小腸腫瘤與症候群</a></li>
              
                <li><a href="/pages/1-36.html">Celiac Disease</a></li>
              
                <li><a href="/pages/1-37.html">Acute/Chronic Diarrhea</a></li>
              
                <li><a href="/pages/1-38.html">小腸疾病-腹瀉與吸收障礙</a></li>
              
                <li><a href="/pages/1-39.html">上消化道-上消化道出血</a></li>
              
                <li><a href="/pages/1-40.html">上消化道-胃部疾病</a></li>
              
                <li><a href="/pages/1-41.html">上消化道-吞嚥困難與食道疾病</a></li>
              
                <li><a href="/pages/1-42.html">Esophageal Varices</a></li>
              
                <li><a href="/pages/1-43.html">UGI bleeding </a></li>
              
                <li><a href="/pages/1-44.html">Gastric Cancer</a></li>
              
                <li><a href="/pages/1-45.html">Zollinger-Ellison Syndrome</a></li>
              
                <li><a href="/pages/1-46.html">Gastritis</a></li>
              
                <li><a href="/pages/1-47.html">Peptic Ulcer Disease</a></li>
              
                <li><a href="/pages/1-48.html">Diverticula</a></li>
              
                <li><a href="/pages/1-49.html">Esophageal Rings</a></li>
              
                <li><a href="/pages/1-50.html">Plummer-Vinson Syndrome</a></li>
              
                <li><a href="/pages/1-51.html">食道癌</a></li>
              
                <li><a href="/pages/1-52.html">Achalasia</a></li>
              
                <li><a href="/pages/1-53.html">GERD </a></li>
              
                <li><a href="/pages/1-54.html">Dysphagia 吞嚥困難</a></li>
              
                <li><a href="/pages/1-55.html">GI</a></li>
              
                <li><a href="/pages/1-56.html">ACLS 需要圖片喔</a></li>
              
                <li><a href="/pages/1-57.html">呼吸器</a></li>
              
                <li><a href="/pages/1-58.html">肺癌</a></li>
              
                <li><a href="/pages/1-59.html">EKG</a></li>
              
                <li><a href="/pages/1-60.html">心衰竭</a></li>
              
                <li><a href="/pages/1-61.html">高血脂</a></li>
              
                <li><a href="/pages/1-62.html">Syncope （內容太少了喔）</a></li>
              
                <li><a href="/pages/1-63.html">Cardiomyopathy</a></li>
              
                <li><a href="/pages/1-64.html">瓣膜性心臟病</a></li>
              
                <li><a href="/pages/1-65.html">心律不整</a></li>
              
                <li><a href="/pages/1-66.html">心臟電生理</a></li>
              
                <li><a href="/pages/1-67.html">CV-整體修改建議如下</a></li>
              
                <li><a href="/pages/1-68.html">Peripheral Artery Disease (PAD)</a></li>
              
                <li><a href="/pages/1-69.html">心包疾病 Pericarditis disease</a></li>
              
                <li><a href="/pages/1-70.html">Ischemic heart disease（IHD）</a></li>
              
                <li><a href="/pages/1-71.html">✅模板試作(HTN)</a></li>
              
                <li><a href="/pages/1-72.html">APACHE</a></li>
              
                <li><a href="/pages/1-73.html">SOFA</a></li>
              
                <li><a href="/pages/1-74.html">Lung abscess</a></li>
              
                <li><a href="/pages/1-75.html">Pneumonia</a></li>
              
                <li><a href="/pages/1-76.html">胸腔基礎</a></li>
              
                <li><a href="/pages/1-77.html">Respiratory failure</a></li>
              
                <li><a href="/pages/1-78.html">Pleural effusion</a></li>
              
                <li><a href="/pages/1-79.html">Sleep apnea </a></li>
              
                <li><a href="/pages/1-80.html">Pulmonary embolism</a></li>
              
                <li><a href="/pages/1-81.html">Acute Respiratory Distress Syndrome (ARDS)</a></li>
              
                <li><a href="/pages/1-82.html">執業和環境造成 </a></li>
              
                <li><a href="/pages/1-83.html">Critical care</a></li>
              
                <li><a href="/pages/1-84.html">Hypersensitivity pneumonitis </a></li>
              
                <li><a href="/pages/1-85.html">Interstitial lung disease</a></li>
              
                <li><a href="/pages/1-86.html">Cystic fibrosis</a></li>
              
                <li><a href="/pages/1-87.html">Bronchiectasis </a></li>
              
                <li><a href="/pages/1-88.html">COPD</a></li>
              
                <li><a href="/pages/1-89.html">TRALI</a></li>
              
                <li><a href="/pages/1-90.html">氣喘</a></li>
              
                <li><a href="/pages/1-91.html">DM foot</a></li>
              
                <li><a href="/pages/1-92.html">META</a></li>
              
                <li><a href="/pages/1-93.html">編輯格式</a></li>
              
                <li><a href="/pages/1-94.html">限制性肺疾病</a></li>
              
                <li><a href="/pages/1-95.html">主動脈剝離</a></li>
              
                <li><a href="/pages/1-96.html">Aneurysm</a></li>
              
                <li><a href="/pages/1-97.html">Acute coronary syndrome</a></li>
              
                <li><a href="/pages/1-98.html">肋膜疾病 </a></li>
              
                <li><a href="/pages/1-99.html">Respiratory failure</a></li>
              
                <li><a href="/pages/1-100.html">胸內</a></li>
              
                <li><a href="/pages/1-101.html">Cardiac neoplasm</a></li>
              
                <li><a href="/pages/1-102.html">發燒</a></li>
              
                <li><a href="/pages/1-103.html">休克</a></li>
              
                <li><a href="/pages/1-104.html">內科值班常見情形</a></li>
              
                <li><a href="/pages/1-105.html">Vascular disease</a></li>
              
                <li><a href="/pages/1-106.html">靜脈血栓栓塞症（Venous Thromboembolism, VTE）</a></li>
              
                <li><a href="/pages/1-107.html">Aortic disease</a></li>
              
                <li><a href="/pages/1-108.html">圖庫資源</a></li>
              
                <li><a href="/pages/1-109.html">高血壓</a></li>
              
                <li><a href="/pages/1-110.html">Coronary artery disease</a></li>
              
                <li><a href="/pages/1-111.html">感染</a></li>
              
                <li><a href="/pages/1-112.html">TB</a></li>
              
            </ul>
          </li>
        
          <li>
            <h3>其他科</h3>
            <ul>
              
                <li><a href="/pages/2-0.html">乾癬</a></li>
              
                <li><a href="/pages/2-1.html">皮膚炎/濕疹和炎症性疾病</a></li>
              
                <li><a href="/pages/2-2.html">藥物疹</a></li>
              
                <li><a href="/pages/2-3.html">AI prompt</a></li>
              
                <li><a href="/pages/2-4.html">大綱架構</a></li>
              
                <li><a href="/pages/2-5.html">結膜</a></li>
              
                <li><a href="/pages/2-6.html">皮膚腫瘤/皮膚增生</a></li>
              
                <li><a href="/pages/2-7.html">眼瞼</a></li>
              
                <li><a href="/pages/2-8.html">水泡疾病</a></li>
              
                <li><a href="/pages/2-9.html">淚液系統</a></li>
              
                <li><a href="/pages/2-10.html">眼科</a></li>
              
                <li><a href="/pages/2-11.html">圖庫資源</a></li>
              
                <li><a href="/pages/2-12.html">先天性疾病</a></li>
              
                <li><a href="/pages/2-13.html">感染性皮膚病</a></li>
              
                <li><a href="/pages/2-14.html">皮膚科</a></li>
              
                <li><a href="/pages/2-15.html">皮膚色素病</a></li>
              
                <li><a href="/pages/2-16.html"></a></li>
              
                <li><a href="/pages/2-17.html">自體免疫性疾病</a></li>
              
                <li><a href="/pages/2-18.html">ENT</a></li>
              
                <li><a href="/pages/2-19.html">麻醉</a></li>
              
                <li><a href="/pages/2-20.html">復健科</a></li>
              
                <li><a href="/pages/2-21.html">NEURO</a></li>
              
                <li><a href="/pages/2-22.html">精神科</a></li>
              
            </ul>
          </li>
        
          <li>
            <h3>外科</h3>
            <ul>
              
                <li><a href="/pages/3-0.html">深層靜脈栓塞（Deep vein thrombosis, DVT）</a></li>
              
                <li><a href="/pages/3-1.html">上肢深層靜脈栓塞（Upper Extremity Deep Vein Thrombosis, UEDVT）</a></li>
              
                <li><a href="/pages/3-2.html">肺栓塞（Pulmonary Embolism）</a></li>
              
                <li><a href="/pages/3-3.html">二尖瓣狹窄（Mitral Valve Stenosis） </a></li>
              
                <li><a href="/pages/3-4.html">周邊動脈阻塞性疾病(Peripheral artery occlusion disease, PAOD) </a></li>
              
                <li><a href="/pages/3-5.html">感染性心內膜炎（Infective endocarditis）</a></li>
              
                <li><a href="/pages/3-6.html">人造瓣膜的選擇(Prosthetic valve) </a></li>
              
                <li><a href="/pages/3-7.html">主動脈逆流（Aortic Regurgitation, AR) </a></li>
              
                <li><a href="/pages/3-8.html">主動脈瓣狹窄（Aortic Stenosis) </a></li>
              
                <li><a href="/pages/3-9.html">二尖瓣閉鎖不全（Mitral Regurgitation）</a></li>
              
                <li><a href="/pages/3-10.html">開放性動脈導管（Patent Ductus Arteriosus, PDA）</a></li>
              
                <li><a href="/pages/3-11.html">部份肺靜脈回流異常（Partial anomalous pulmonary venous return, PAPVR）</a></li>
              
                <li><a href="/pages/3-12.html">肺動脈狹窄（Pulmonary Stenosis）</a></li>
              
                <li><a href="/pages/3-13.html">三心房（cor triatriatum）</a></li>
              
                <li><a href="/pages/3-14.html">右心室雙出口（Double-Outlet Right Ventricle, DORV）</a></li>
              
                <li><a href="/pages/3-15.html">主動脈弓狹窄（CoA）</a></li>
              
                <li><a href="/pages/3-16.html">主動脈弓中斷（Interrupted Aortic Arch, IAA）</a></li>
              
                <li><a href="/pages/3-17.html">心室中膈缺損（Ventricular Septal Defect）</a></li>
              
                <li><a href="/pages/3-18.html">心房中膈缺損（Atrial Septal Defect）</a></li>
              
                <li><a href="/pages/3-19.html">兩側右心房 </a></li>
              
                <li><a href="/pages/3-20.html">肺動脈閉鎖 Pulmonary Valve Atresia</a></li>
              
                <li><a href="/pages/3-21.html">Ebstein anomaly</a></li>
              
                <li><a href="/pages/3-22.html">三尖瓣閉鎖 Tricuspid Valve Atresia</a></li>
              
                <li><a href="/pages/3-23.html">動脈幹 Persistent Truncus Arteriosus</a></li>
              
                <li><a href="/pages/3-24.html">全肺靜脈回流異常（Total anomalous pulmonary venous return, TAPVR）</a></li>
              
                <li><a href="/pages/3-25.html">頭部創傷/顱內出血</a></li>
              
                <li><a href="/pages/3-26.html">Eisenmenger’s Syndrome</a></li>
              
                <li><a href="/pages/3-27.html">神外術後電解質常見失衡</a></li>
              
                <li><a href="/pages/3-28.html">顱內壓</a></li>
              
                <li><a href="/pages/3-29.html">發紺型先天心臟病</a></li>
              
                <li><a href="/pages/3-30.html">左心發育不全 Hypoplastic Left Heart Syndrome </a></li>
              
                <li><a href="/pages/3-31.html">手掌腳掌dermis很厚，可以試著做secondary healing</a></li>
              
                <li><a href="/pages/3-32.html">法洛氏四重症（Tetralogy of Fallot）</a></li>
              
                <li><a href="/pages/3-33.html">大動脈轉位 Transposition of the great arteries, TGA</a></li>
              
                <li><a href="/pages/3-34.html">(V) 冠狀動脈繞道術（Coronary artery bypass graft, CABG）</a></li>
              
                <li><a href="/pages/3-35.html">(V) 主動脈剝離 Aortic Dissection</a></li>
              
                <li><a href="/pages/3-36.html">(V) 動脈瘤 </a></li>
              
                <li><a href="/pages/3-37.html">(X) Transmyocardial laser revascularization(TMLR) </a></li>
              
                <li><a href="/pages/3-38.html">心臟移植</a></li>
              
                <li><a href="/pages/3-39.html">心臟腫瘤</a></li>
              
                <li><a href="/pages/3-40.html">機械式循環輔助(Mechanical Circulatory Support, MCS) </a></li>
              
                <li><a href="/pages/3-41.html">CO2栓塞 </a></li>
              
                <li><a href="/pages/3-42.html">慢性靜脈疾病 </a></li>
              
                <li><a href="/pages/3-43.html">周邊血管疾病</a></li>
              
                <li><a href="/pages/3-44.html">心臟瓣膜疾病</a></li>
              
                <li><a href="/pages/3-45.html">非發紺型先天性心臟病 </a></li>
              
                <li><a href="/pages/3-46.html">先天性心臟病</a></li>
              
                <li><a href="/pages/3-47.html">腦死判定</a></li>
              
                <li><a href="/pages/3-48.html">昏迷指數</a></li>
              
                <li><a href="/pages/3-49.html">NS</a></li>
              
                <li><a href="/pages/3-50.html">顱頸交界處異常(Craniocervical junction anomalies)=Chiari malformation</a></li>
              
                <li><a href="/pages/3-51.html">三叉神經痛</a></li>
              
                <li><a href="/pages/3-52.html">腦瘤</a></li>
              
                <li><a href="/pages/3-53.html">Spinal cord injury[復健]</a></li>
              
                <li><a href="/pages/3-54.html">脊椎疾病</a></li>
              
                <li><a href="/pages/3-55.html">血管畸形</a></li>
              
                <li><a href="/pages/3-56.html">顱內出血</a></li>
              
                <li><a href="/pages/3-57.html">冠狀動脈疾病及冠狀動脈繞道手術</a></li>
              
                <li><a href="/pages/3-58.html">CVS</a></li>
              
                <li><a href="/pages/3-59.html">Acute adomen</a></li>
              
                <li><a href="/pages/3-60.html">GS</a></li>
              
            </ul>
          </li>
        
          <li>
            <h3>婦產科</h3>
            <ul>
              
                <li><a href="/pages/4-0.html">男性不孕</a></li>
              
                <li><a href="/pages/4-1.html">胚胎學</a></li>
              
                <li><a href="/pages/4-2.html">子宮肌瘤</a></li>
              
                <li><a href="/pages/4-3.html">陰道鏡</a></li>
              
                <li><a href="/pages/4-4.html">不孕症概論</a></li>
              
                <li><a href="/pages/4-5.html">子宮內膜增生</a></li>
              
                <li><a href="/pages/4-6.html">圖庫資源</a></li>
              
                <li><a href="/pages/4-7.html">子宮鏡</a></li>
              
                <li><a href="/pages/4-8.html">陰道癌</a></li>
              
                <li><a href="/pages/4-9.html">外陰癌</a></li>
              
                <li><a href="/pages/4-10.html">子宮內膜癌</a></li>
              
                <li><a href="/pages/4-11.html">腹腔鏡</a></li>
              
                <li><a href="/pages/4-12.html">OP</a></li>
              
                <li><a href="/pages/4-13.html">泌尿道感染</a></li>
              
                <li><a href="/pages/4-14.html">骨盆腔器官脱垂</a></li>
              
                <li><a href="/pages/4-15.html">尿失禁</a></li>
              
                <li><a href="/pages/4-16.html">排尿生理學與尿路動力學檢查</a></li>
              
                <li><a href="/pages/4-17.html">URO</a></li>
              
                <li><a href="/pages/4-18.html">子宮腔沾黏</a></li>
              
                <li><a href="/pages/4-19.html">卵巢過度刺激症候群</a></li>
              
                <li><a href="/pages/4-20.html">女性不孕</a></li>
              
                <li><a href="/pages/4-21.html">人工協助生殖技術</a></li>
              
                <li><a href="/pages/4-22.html">不孕症</a></li>
              
                <li><a href="/pages/4-23.html">反覆性流產</a></li>
              
                <li><a href="/pages/4-24.html">骨質疏鬆症</a></li>
              
                <li><a href="/pages/4-25.html">更年期及荷爾蒙治療</a></li>
              
                <li><a href="/pages/4-26.html">多囊性卵巢症候群</a></li>
              
                <li><a href="/pages/4-27.html">原發性卵巢功能不全</a></li>
              
                <li><a href="/pages/4-28.html">無月經</a></li>
              
                <li><a href="/pages/4-29.html">青春期</a></li>
              
                <li><a href="/pages/4-30.html">月經週期</a></li>
              
                <li><a href="/pages/4-31.html">女性內分泌學</a></li>
              
                <li><a href="/pages/4-32.html">婦科急症</a></li>
              
                <li><a href="/pages/4-33.html">婦科手術併發症</a></li>
              
                <li><a href="/pages/4-34.html">口服避孕藥</a></li>
              
                <li><a href="/pages/4-35.html">子宮外孕</a></li>
              
                <li><a href="/pages/4-36.html">子宮內膜異位症</a></li>
              
                <li><a href="/pages/4-37.html">婦科感染症</a></li>
              
                <li><a href="/pages/4-38.html">一般婦科學</a></li>
              
                <li><a href="/pages/4-39.html">妊娠滋養層疾病</a></li>
              
                <li><a href="/pages/4-40.html">子宮頸癌</a></li>
              
                <li><a href="/pages/4-41.html">子宮頸癌前病變</a></li>
              
                <li><a href="/pages/4-42.html">人類乳突病毒與子宮頸疫苗</a></li>
              
                <li><a href="/pages/4-43.html">卵巢性索間質腫瘤</a></li>
              
                <li><a href="/pages/4-44.html">卵巢生殖細胞腫瘤</a></li>
              
                <li><a href="/pages/4-45.html">卵巢上皮細胞腫瘤</a></li>
              
                <li><a href="/pages/4-46.html">卵巢囊腫或腫瘤概論</a></li>
              
                <li><a href="/pages/4-47.html">婦科良性與惡性腫瘤</a></li>
              
                <li><a href="/pages/4-48.html">解剖學</a></li>
              
                <li><a href="/pages/4-49.html">懷孕併甲狀腺疾病</a></li>
              
                <li><a href="/pages/4-50.html">妊娠糖尿病</a></li>
              
                <li><a href="/pages/4-51.html">妊娠高血壓與子癲前症</a></li>
              
                <li><a href="/pages/4-52.html">產褥期</a></li>
              
                <li><a href="/pages/4-53.html">新生兒</a></li>
              
                <li><a href="/pages/4-54.html">產後出血</a></li>
              
                <li><a href="/pages/4-55.html">過期妊娠與催生</a></li>
              
                <li><a href="/pages/4-56.html">流產與終止妊娠</a></li>
              
                <li><a href="/pages/4-57.html">生產胎兒監視</a></li>
              
                <li><a href="/pages/4-58.html">肩難產</a></li>
              
                <li><a href="/pages/4-59.html">正常分娩與產程遲滯</a></li>
              
                <li><a href="/pages/4-60.html">生產評估</a></li>
              
                <li><a href="/pages/4-61.html">安胎</a></li>
              
                <li><a href="/pages/4-62.html">早產、早期陣痛與早期破水</a></li>
              
                <li><a href="/pages/4-63.html">產前出血</a></li>
              
                <li><a href="/pages/4-64.html">產前胎兒評估</a></li>
              
                <li><a href="/pages/4-65.html">胎兒健康</a></li>
              
                <li><a href="/pages/4-66.html">產檢</a></li>
              
                <li><a href="/pages/4-67.html">產婦胎兒生理學</a></li>
              
                <li><a href="/pages/4-68.html">胚胎解剖學</a></li>
              
                <li><a href="/pages/4-69.html">高危險妊娠</a></li>
              
                <li><a href="/pages/4-70.html">產後時期</a></li>
              
                <li><a href="/pages/4-71.html">生產時期</a></li>
              
                <li><a href="/pages/4-72.html">產前時期</a></li>
              
                <li><a href="/pages/4-73.html">OB</a></li>
              
                <li><a href="/pages/4-74.html">GYN</a></li>
              
            </ul>
          </li>
        
          <li>
            <h3>籌備行政事項</h3>
            <ul>
              
                <li><a href="/pages/5-0.html">工程組測試頁面</a></li>
              
                <li><a href="/pages/5-1.html">婦產科</a></li>
              
                <li><a href="/pages/5-2.html">示範ITP</a></li>
              
                <li><a href="/pages/5-3.html">外科</a></li>
              
                <li><a href="/pages/5-4.html">✅模板試作(HTN)</a></li>
              
                <li><a href="/pages/5-5.html">FC架構參考</a></li>
              
                <li><a href="/pages/5-6.html">內科</a></li>
              
                <li><a href="/pages/5-7.html">兒科</a></li>
              
            </ul>
          </li>
        
      </ul>
    </div>
    <div class="twelve wide column">
      <div class="ui segment">
        <div id="pageContent"><html lang="en-US"><head>
		<title>高血脂</title>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
		<meta name="created" content="2025-02-26T17:58:00.0000000">
	</head>
	<body data-absolute-enabled="true" style="font-family:Calibri;font-size:11pt">
		<div style="position:absolute;left:48px;top:115px;width:746px">
			<ul>
				<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">定義</span><span lang="zh-TW" style="font-family:Microsoft JhengHei;font-size:16pt;color:black">（Definition）</span></p>
				<ul>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">血脂異常：</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#2e75b5">Total cholesterol、LDL-C 或triglyceride升高</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">，或</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#2e75b5">HDL降低</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">。</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">LDL-C是主要的致動脈粥狀硬化膽固醇，與ASCVD（動脈粥狀硬化性心血管疾病，如冠狀動脈疾病 CAD、腦中風） 相關。</span></li>
				</ul>
				</li>
				<br>
				<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">流行病學</span><span lang="zh-TW" style="font-family:Microsoft JhengHei;font-size:16pt;color:black">（Epidemiology）</span></p>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt">根據中華民國血脂及動脈硬化學會2022年指引：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:black">高血脂症在台灣的流行病學資料顯示，隨著生活方式的改變以及人口老化，心血管疾病的風險逐年上升。在成人中，約 30% 以上的人群存在某種形式的高血脂（例如：高總膽固醇、高LDL-C、低HDL-C 或高三酸甘油酯），並且這一比例隨著年齡的增長而上升。</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">男性通常在較年輕的年齡段出現高血脂問題，而女性則多見於更年期後，這是由於女性在更年期後，隨著雌激素水平下降，對心血管的保護作用減弱，導致膽固醇水平的升高。</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">高血脂與多種心血管疾病密切相關，包括冠狀動脈疾病（Coronary Artery Disease）、外周動脈疾病（Peripheral Artery Disease）、缺血性中風（Ischemic Stroke）等。</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">研究顯示，患有高血脂的個體，其心血管事件的風險大大增加，且對高風險群體（如糖尿病、吸煙者、高血壓者）的影響尤為顯著。</span></li>
					</ul>
					</li>
				</ul>
				</li>
				<br>
				<li><h2 style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">Lipoprotein 類別與功能</span></h2>
				</li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">Lipoprotein 類型</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">主要成分</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">功能</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">關鍵 Apoprotein</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Chylomicrons</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">TG（90%）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">攜帶飲食脂肪（TG）從腸道到肝臟</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ApoB-48、ApoC-II、ApoE</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">VLDL (Very-Low-Density Lipoprotein)</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">TG（55%）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">肝臟合成，運輸內源性TG到周邊組織</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ApoB-100、ApoC-II、ApoE</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">IDL (Intermediate-Density Lipoprotein)</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">TG（40%）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">VLDL 代謝中間產物，可轉換為 LDL</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ApoB-100、ApoE</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">LDL (Low-Density Lipoprotein)</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Cholesterol（50%）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">運輸膽固醇至周邊組織</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ApoB-100</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">HDL (High-Density Lipoprotein)</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Protein（50%）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">反向膽固醇運輸，將膽固醇帶回肝臟</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ApoA-I、ApoA-II</span></td>
					</tr>
				</tbody></table>
				<br>
				<li><h3 style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">病理生理（Pathophysiology）</span></h3>
				<ul>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt">動脈粥樣硬化：</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#2e75b5">高LDL-C會積聚於血管壁內</span><span style="font-family:Microsoft JhengHei;font-size:14pt">，形成動脈粥樣硬化斑塊，進一步引發血管狹窄或閉塞，影響血流，增加心血管事件風險（心肌梗死、缺血性中風）。</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt">低HDL-C：低密度脂蛋白膽固醇（HDL-C）具有反向膽固醇運輸作用，幫助清除血管內的膽固醇。HDL-C水平低時，會加重心血管風險。</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt">高三酸甘油酯（TG）：高TG與心血管疾病風險相關，尤其是與動脈粥樣硬化密切關聯。高TG還可能引發急性胰臟炎。</span></li>
				</ul>
				</li>
			</ul>
			<br>
			<br>
			<h2 style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">Lipoprotein 類別與功能</span></h2>
			<br>
			<h3 style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">病理生理（Pathophysiology）</span></h3>
			<br>
			<h4 style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">病因</span></h4>
			<ul>
				<li><h4 style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">病因</span></h4>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt">Primary（原發性，遺傳性）</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:black">Familial combined hypercholesterolemia（家族性混合型高膽固醇血症）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">Familial hypertriglyceridemia（家族性高三酸甘油酯血症）</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">Secondary（繼發性）</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:black">代謝性疾病：DM（糖尿病）、hypothyroidism（甲狀腺功能低下）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">肝腎疾病：Cholestatic liver disease（膽汁鬱積性肝病）、nephrotic syndrome（腎病症候群）、chronic renal disease（慢性腎臟病）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">生活習慣：肥胖、吸菸、過量飲酒</span></li>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">藥物：</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">Thiazide diuretics</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">β-blockers</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">口服避孕藥</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">Clozapine（抗精神病藥</span></li>
						</ul>
						</li>
					</ul>
					</li>
				</ul>
				</li>
				<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">病史與理學檢查（History/PE）</span></p>
				<ul>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">大多數患者無明顯症狀</span></li>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">嚴重高脂血症可能有體徵</span></p>
					<ul>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">Xanthomata（黃瘤）：</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">Eruptive xanthomas（爆發性黃瘤）：瘙癢性結節</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">Tuberous xanthomas（結節性黃瘤）：肘部、膝部結節</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">Palmar xanthomas（掌紋黃瘤）：掌紋橘色條紋</span></li>
						</ul>
						</li>
						<li><span style="font-family:Microsoft JhengHei;color:black">Xanthelasma（眼瞼黃斑瘤）：眼周黃色脂肪沉積</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">Lipemia retinalis（乳糜血症性視網膜病變）：視網膜血管呈乳白色</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">Corneal arcus（角膜弧）：角膜基質脂質沉積</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">嚴重高三酸甘油酯血症（&gt;500 mg/dL）可能導致急性胰臟炎（pancreatitis）</span></li>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">可能有家族性高脂血症（familial hyperlipidemia）病史</span></li>
				</ul>
				</li>
				<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">繼發性高脂血症常見病因</span></p>
				<ul>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">Cushing syndrome</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">Hypothyroidism（甲狀腺功能低下）</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">Nephrotic syndrome（腎病症候群）</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">Cholestasis（膽汁鬱積）</span></li>
				</ul>
				</li>
				<br>
				<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">篩檢建議</span></p>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">高血脂篩檢建議（Dyslipidemia Screening）</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:black">依據 2023 ACC/AHA、2022 ESC/EAS 及 2022 台灣動脈硬化學會（TAS）指南，高血脂的篩檢應考量年齡、危險因子、家族病史，篩檢方法主要以空腹或非空腹血脂檢測（Lipid Profile） 為主。</span></li>
						<br>
					</ul>
					</li>
				</ul>
				</li>
				<li><h2 style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">一般成人族群篩檢建議</span></h2>
				</li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="width:108;border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">族群</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">篩檢建議</span></td>
					</tr>
					<tr>
						<td style="width:108;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">20-39 歲成人</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">有心血管危險因子者</span><span style="font-family:Microsoft JhengHei;color:black">（如糖尿病、肥胖、吸菸、高血壓、家族史），應</span><span style="font-family:Microsoft JhengHei;color:black">每 4-6 年檢測 1 次</span><span style="font-family:Microsoft JhengHei;color:black">。</span></td>
					</tr>
					<tr>
						<td style="width:108;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">40-75 歲成人</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">所有人皆應篩檢</span><span style="font-family:Microsoft JhengHei;color:black">，</span><span style="font-family:Microsoft JhengHei;color:black">至少每4-6年1次</span><span style="font-family:Microsoft JhengHei;color:black">，若為</span><span style="font-family:Microsoft JhengHei;color:black">高風險族群</span><span style="font-family:Microsoft JhengHei;color:black">（如糖尿病或心血管疾病）應</span><span style="font-family:Microsoft JhengHei;color:black">每 1-2 年檢測 1 次</span><span style="font-family:Microsoft JhengHei;color:black">。</span></td>
					</tr>
					<tr>
						<td style="width:108;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">&gt; 75 歲老年人</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">仍應持續監測</span><span style="font-family:Microsoft JhengHei;color:black">，但應根據個人健康狀況與餘命決定是否積極治療。</span></td>
					</tr>
				</tbody></table>
				<br>
				<li><h2 style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">高風險族群的篩檢建議</span></h2>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">以下高風險族群應每1-2 年檢測1次，必要時可每年追蹤： </span></p>
					<ul>
						<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">家族性高膽固醇血症（FH）家族史（1 等親LDL </span><span lang="x-IV" style="font-family:Cambria Math;color:black">≥</span><span style="font-family:Microsoft JhengHei;color:black"> 190 mg/dL或早發心血管病史）</span></li>
						<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">糖尿病（Diabetes Mellitus, DM）</span></li>
						<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">慢性腎病（Chronic Kidney Disease, CKD, eGFR &lt; 60）</span></li>
						<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">動脈粥樣硬化性心血管疾病（ASCVD）病史</span></li>
						<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">高血壓（Hypertension）</span></li>
						<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">肥胖（BMI </span><span lang="x-IV" style="font-family:Cambria Math;color:black">≥</span><span style="font-family:Microsoft JhengHei;color:black"> 30）</span></li>
						<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">吸菸者</span></li>
						<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">高膽固醇血症（LDL-C </span><span lang="x-IV" style="font-family:Cambria Math;color:black">≥</span><span style="font-family:Microsoft JhengHei;color:black"> 190 mg/dL）</span></li>
					</ul>
					</li>
				</ul>
				</li>
				<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">診斷（Diagnosis）</span></p>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">首選檢查：Lipid profile（血脂分析）</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">Total cholesterol ↑</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">LDL-C ↑</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">Triglycerides ↑</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">HDL ↓</span></li>
					</ul>
					</li>
				</ul>
				</li>
				<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">診斷標準：</span></p>
				<ul>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000">總膽固醇（Total Cholesterol, TC）</span><span style="font-family:Cambria Math;font-size:14pt;color:#c00000">≥</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000"> 200 mg/dL</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000">低密度脂蛋白（LDL-C）</span><span style="font-family:Cambria Math;font-size:14pt;color:#c00000">≥</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000"> 130 mg/dL</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">（建議控制在 &lt; 100 mg/dL，對於高風險者 &lt; 70 mg/dL）</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000">高密度脂蛋白（HDL-C）&lt; 40 mg/dL（男性）或 &lt; 50 mg/dL（女性）</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000">三酸甘油酯（Triglycerides, TG）</span><span style="font-family:Cambria Math;font-size:14pt;color:#c00000">≥</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000"> 150 mg/dL</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">（嚴重高TG &gt; 500 mg/dL 會增加胰臟炎風險）</span></li>
				</ul>
				</li>
				<br>
				<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">根據 2022 年台灣動脈硬化學會（TAS）指南，針對動脈粥樣硬化性心血管疾病（ASCVD）的LDL-C目標值如下：</span></p>
				<ul>
					<li style="list-style-type:circle"><h3 style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">LDL-C目標值依據ASCVD風險分層</span></h3>
					</li>
				</ul>
				</li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="width:105;border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">風險等級</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">定義</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">LDL-C 目標值</span></td>
					</tr>
					<tr>
						<td style="width:105;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">極高風險（Very High Risk）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">已確診 </span><span style="font-family:Microsoft JhengHei;color:black">ASCVD</span><span style="font-family:Microsoft JhengHei;color:black">（如心肌梗塞、腦中風、周邊動脈疾病），或 </span><span style="font-family:Microsoft JhengHei;color:black">糖尿病 + 靶器官損害</span><span style="font-family:Microsoft JhengHei;color:black">（如微量白蛋白尿）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">&lt; 55 mg/dL（1.4 mmol/L）</span><span style="font-family:Microsoft JhengHei;color:black"> 且降幅 </span><span style="font-family:Microsoft JhengHei;color:black">≥ 50%</span></td>
					</tr>
					<tr>
						<td style="width:105;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">高風險（High Risk）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">糖尿病</span><span style="font-family:Microsoft JhengHei;color:black">（無靶器官損害）、慢性腎病（CKD stage 3-4）、10 年風險 &gt; 20%</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">&lt; 70 mg/dL（1.8 mmol/L）</span><span style="font-family:Microsoft JhengHei;color:black"> 且降幅 </span><span style="font-family:Microsoft JhengHei;color:black">≥ 50%</span></td>
					</tr>
					<tr>
						<td style="width:105;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">中等風險（Moderate Risk）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">2 個以上心血管危險因子（高血壓、吸菸、家族史等），10 年風險 10-20%</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">&lt; 100 mg/dL（2.6 mmol/L）</span></td>
					</tr>
					<tr>
						<td style="width:105;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">低風險（Low Risk）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">無主要心血管危險因子或僅有 1 個危險因子，</span><span style="font-family:Microsoft JhengHei;color:black">10 年風險 &lt; 10%</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">&lt; 130 mg/dL（3.4 mmol/L）</span></td>
					</tr>
				</tbody></table>
				<br>
				<li><h4 style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">治療（Treatment）：</span></h4>
				<ul>
					<li style="list-style-type:circle"><h4 style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">治療主要分為</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000">生活方式調整（Lifestyle Modification）與藥物治療（Pharmacologic Therapy）</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">。</span></h4>
					</li>
					<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">生活方式調整</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">（適用所有患者）：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:black">低脂飲食（減少紅肉攝取，增加膳食纖維）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">規律有氧運動</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">減重</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">藥物治療指引</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">（依據 American College of Cardiology/American Heart Association）</span></p>
					<ul>
						<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:#70ad47;font-weight:bold">Statins（他汀類）為首選藥物</span></li>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">高強度 Statin</span><span style="font-family:Microsoft JhengHei;color:black">（降低 LDL-C &gt;50%）：</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">Atorvastatin 40–80 mg</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">Rosuvastatin 20–40 mg</span></li>
						</ul>
						</li>
						<li><span style="font-family:Microsoft JhengHei;color:black">中等強度 Statin</span><span style="font-family:Microsoft JhengHei;color:black">（降低 LDL-C 30%–50%）</span></li>
						<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">高三酸甘油酯血症治療</span></p>
						<ul>
							<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">初始治療</span><span style="font-family:Microsoft JhengHei;color:black">：生活方式調整、治療繼發性病因（如糖尿病、慢性腎病）</span></li>
							<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">若 ASCVD 風險 ≥7.5%</span><span style="font-family:Microsoft JhengHei;color:black">，可考慮 statins</span></li>
							<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">預防胰臟炎</span><span style="font-family:Microsoft JhengHei;color:black">（triglycerides ≥1000 mg/dL）：</span><span style="font-family:Microsoft JhengHei;color:black">Fibrate（貝特類藥物）</span></li>
						</ul>
						</li>
					</ul>
					</li>
				</ul>
				</li>
				<br>
				<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">Dyslipidemia 藥物整理</span></p>
				<ul>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">Statins 仍為第一線藥物</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">，但若 LDL 降幅不足，可加用 </span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">Ezetimibe 或 PCSK9 抑制劑</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">。</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">TG &gt; 500 mg/dL 時，優先使用 Fibrates 或 Omega-3，避免胰臟炎風險</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">。</span></li>
				</ul>
				</li>
			</ul>
			<br>
			<br>
			<h2 style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">一般成人族群篩檢建議</span></h2>
			<br>
			<h2 style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">高風險族群的篩檢建議</span></h2>
			<br>
			<h3 style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">LDL-C目標值依據ASCVD風險分層</span></h3>
			<br>
			<h4 style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">治療（Treatment）：</span></h4>
			<h4 style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">治療主要分為</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000">生活方式調整（Lifestyle Modification）與藥物治療（Pharmacologic Therapy）</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">。</span></h4>
			<br>
			<table style="border:1px solid;border-collapse:collapse">
				<tbody><tr>
					<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">藥物類別</span></td>
					<td style="width:119;border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">代表藥物</span></td>
					<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">作用機轉</span></td>
					<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">適應症</span></td>
					<td style="width:134;border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">主要副作用</span></td>
					<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">考點</span></td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Statins</span></td>
					<td style="width:119;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Atorvastatin, Rosuvastatin</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抑制</span><span style="font-family:Microsoft JhengHei;color:black">HMG-CoA reductase</span><span style="font-family:Microsoft JhengHei;color:black">，降低肝臟膽固醇合成，增加</span><span style="font-family:Microsoft JhengHei;color:black">LDL受體</span><span style="font-family:Microsoft JhengHei;color:black"> 表現</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">高LDL-C</span><span style="font-family:Microsoft JhengHei;color:black">（首選）、ASCVD 預防</span></td>
					<td style="width:134;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">肝毒性</span><span style="font-family:Microsoft JhengHei;color:black">、</span><span style="font-family:Microsoft JhengHei;color:black">肌肉病變（CK ↑）</span></td>
					<td style="border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">首選藥物，Statin + Fibrate → 肌肉毒性</span></p>
					<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:red">↓LDL </span></p>
					</td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Bile Acid Sequestrants（膽酸螯合劑）</span></td>
					<td style="width:119;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Cholestyramine, Colesevelam</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">與膽酸結合，促使膽固醇轉化為膽酸</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">適合年輕患者或孕婦的高膽固醇血症</span></td>
					<td style="width:134;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">胃腸不適（便秘、腹脹）、可能影響脂溶性維生素吸收</span></td>
					<td style="border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:red">↓</span><span style="font-family:Microsoft JhengHei;color:red">LDL</span></p>
					<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">輕微</span><span style="font-family:Microsoft JhengHei;color:red">↑</span><span style="font-family:Microsoft JhengHei;color:red">HDL</span></p>
					</td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Fibrates</span></td>
					<td style="width:119;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Gemfibrozil, Fenofibrate</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">活化</span><span style="font-family:Microsoft JhengHei;color:black">PPAR-α</span><span style="font-family:Microsoft JhengHei;color:black">，增加 LPL活性，降低VLDL 產生</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">高三酸甘油酯（TG &gt;1000 mg/dL）</span><span style="font-family:Microsoft JhengHei;color:black">，預防胰臟炎</span></td>
					<td style="width:134;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">膽結石（cholelithiasis）</span><span style="font-family:Microsoft JhengHei;color:black">、</span><span style="font-family:Microsoft JhengHei;color:black">肌肉毒性</span></td>
					<td style="border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">TG &gt;1000 mg/dL → Fibrate，Statin + Gemfibrozil → 肌肉毒性 ↑</span></p>
					<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:red">↓TG </span></p>
					<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:red">↑HDL </span></p>
					</td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Niacin</span></td>
					<td style="width:119;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Niacin (Vit B3)</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抑制</span><span style="font-family:Microsoft JhengHei;color:black">肝臟 VLDL合成</span><span style="font-family:Microsoft JhengHei;color:black">，增加</span><span style="font-family:Microsoft JhengHei;color:black">HDL</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">提高HDL</span><span style="font-family:Microsoft JhengHei;color:black">，輕度高膽固醇血症</span></td>
					<td style="width:134;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">潮紅（flushing，PGE 介導）</span><span style="font-family:Microsoft JhengHei;color:black">、高尿酸血症（痛風）</span></td>
					<td style="border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">可用 Aspirin減少潮紅反應</span></p>
					<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:red">↓TG </span></p>
					<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:red">↑HDL</span></p>
					</td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Ezetimibe（膽固醇吸收抑制劑）</span></td>
					<td style="width:119;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Ezetimibe</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抑制腸道</span><span style="font-family:Microsoft JhengHei;color:black">NPC1L1 transporter</span><span style="font-family:Microsoft JhengHei;color:black">，減少膽固醇吸收</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">高LDL-C（可與 statin 合併）</span></td>
					<td style="width:134;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">腹瀉、肝功能異常（罕見）</span></td>
					<td style="border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">常與 statins 併用</span></p>
					<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:red">↓LDL </span></p>
					</td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">PCSK9 inhibitors</span></td>
					<td style="width:119;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Alirocumab, Evolocumab</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抑制 PCSK9，增加 </span><span style="font-family:Microsoft JhengHei;color:black">LDL受體表現</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">家族性高膽固醇血症（FH）</span><span style="font-family:Microsoft JhengHei;color:black">，無法耐受 statin 者</span></td>
					<td style="width:134;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">注射部位反應，罕見肝功能異常</span></td>
					<td style="border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">高風險患者（如家族性高膽固醇血症）適用</span></p>
					<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:red">↓LDL </span></p>
					</td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Omega-3 脂肪酸</span></td>
					<td style="width:119;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Fish oil, Icosapent ethyl</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">減少</span><span style="font-family:Microsoft JhengHei;color:black">肝臟VLDL合成</span><span style="font-family:Microsoft JhengHei;color:black">，降低TG</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">中等程度高三酸甘油酯血症（TG 200–500 mg/dL）</span></td>
					<td style="width:134;border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">胃腸不適、魚腥味回流</span></p>
					<br>
					</td>
					<td style="border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">降低 TG，但效果不如fibrates</span></p>
					<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:red">↓TG </span></p>
					</td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">MTP（Microsomal Triglyceride Transfer Protein）抑制劑</span></td>
					<td style="width:119;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Lomitapide</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抑制 microsomal triglyceride transfer protein（MTP），減少 VLDL 產生</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">家族性高膽固醇血症，</span><span style="font-family:Microsoft JhengHei;color:black">適合 </span><span style="font-family:Microsoft JhengHei;color:black">Statins 及 PCSK9 抑制劑效果不佳的患者</span></td>
					<td style="width:134;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">噁心、腹瀉、肝內脂肪堆積（脂肪肝）</span></td>
					<td style="border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">口服劑型，但 </span><span style="font-family:Microsoft JhengHei;color:black">GI 副作用明顯</span><span style="font-family:Microsoft JhengHei;color:black">，需低脂飲食以減少腸胃不適。</span><span style="font-family:Microsoft JhengHei;color:black">需監測肝酶（ALT/AST）</span><span style="font-family:Microsoft JhengHei;color:black">，避免嚴重肝毒性。</span></p>
					<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:red">↓LDL </span></p>
					<br>
					</td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ApoB-100 抑制劑</span></td>
					<td style="width:119;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Mipomersen</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抑制 </span><span style="font-family:Microsoft JhengHei;color:black">ApoB-100 mRNA</span><span style="font-family:Microsoft JhengHei;color:black">，減少 VLDL 和 LDL 生成</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">家族性高膽固醇血症，</span><span style="font-family:Microsoft JhengHei;color:black">適合 </span><span style="font-family:Microsoft JhengHei;color:black">Statins 及 PCSK9 抑制劑效果不佳的患者</span></td>
					<td style="width:134;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">注射部位反應、類流感症狀、肝內脂肪堆積（脂肪肝）</span></td>
					<td style="border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="color:black">皮下注射，常見</span><span style="color:black">注射部位反應</span><span style="color:black">，但主要問題是</span><span style="color:black">肝脂肪增加</span><span style="color:black">，可能影響肝功能。</span><span style="color:black">需監測肝酶（ALT/AST）</span><span style="color:black">，避免嚴重肝毒性。</span></p>
					<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:red">↓LDL </span></p>
					<br>
					</td>
				</tr>
			</tbody></table>
			<br>
			<ul>
				<li><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">依風險等級的治療策略</span></li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">風險族群</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">治療策略</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">低風險（LDL &lt; 130 mg/dL）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">生活方式調整</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">中等風險（LDL 100-129 mg/dL）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">生活方式調整，考慮 Statins</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">高風險（LDL ≥ 100 mg/dL，ASCVD 風險 ≥ 7.5%）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Statins 第一線，若 LDL 不達標可加 Ezetimibe</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">極高風險（LDL ≥ 70 mg/dL，已有 ASCVD 或 FH）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">強效 Statins + Ezetimibe ± PCSK9 抑制劑</span></td>
					</tr>
				</tbody></table>
			</ul>
			<br>
			<p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">REFERENCE：</span></p>
			<ol>
				<li>HARRISON Principles of Internal Medicine 20th Edition</li>
				<li>Boards &amp; Beyonds：Dyslipidemia</li>
				<li><a href="https://www.tas.org.tw/upload/files/1-s2_0-S0929664622001036-main.pdf">https://www.tas.org.tw/upload/files/1-s2_0-S0929664622001036-main.pdf</a></li>
				<li><a href="https://www.tas.org.tw/upload/files/1-s2_0-S0929664622002157-main%20(1).pdf">https://www.tas.org.tw/upload/files/1-s2_0-S0929664622002157-main%20(1).pdf</a></li>
			</ol>
		</div>
		<div style="position:absolute;left:60px;top:5944px;width:624px">
			<p style="margin-top:0pt;margin-bottom:0pt"><span lang="zh-TW" style="font-size:16pt;color:#c00000">建議：</span></p>
			<br>
			<br>
			<p style="margin-top:0pt;margin-bottom:0pt"><span lang="zh-TW" style="font-size:16pt;color:#c00000">請問現行台灣關於/高危險/中危險/以及最近12個月有過Stroke&amp;stenosis活著AF患者的LDL/TG的下降要求量是多少？</span></p>
			<br>
			<br>
			<h3 style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="color:black">歐洲心臟學會（ESC）/歐洲動脈硬化學會（EAS）2019 年脂質異常治療指引</span></h3>
			<table style="border:1px solid;border-collapse:collapse">
				<tbody><tr>
					<td style="border:1px solid;text-align:center"><span style="font-weight:bold">風險分類</span></td>
					<td style="border:1px solid;text-align:center"><span style="font-weight:bold">LDL-C 目標值</span></td>
					<td style="border:1px solid;text-align:center"><span style="font-weight:bold">相對降低幅度</span></td>
				</tr>
				<tr>
					<td style="border:1px solid">非常高風險（如：已知 ASCVD、糖尿病合併器官損害、嚴重慢性腎病）</td>
					<td style="border:1px solid">&lt; 55 mg/dL</td>
					<td style="border:1px solid">≥ 50% 降低</td>
				</tr>
				<tr>
					<td style="border:1px solid">高風險（如：顯著升高的單一危險因子）</td>
					<td style="border:1px solid">&lt; 70 mg/dL</td>
					<td style="border:1px solid">≥ 50% 降低</td>
				</tr>
				<tr>
					<td style="border:1px solid">中等風險</td>
					<td style="border:1px solid">&lt; 100 mg/dL</td>
					<td style="border:1px solid">-</td>
				</tr>
				<tr>
					<td style="border:1px solid">低風險</td>
					<td style="border:1px solid">&lt; 116 mg/dL</td>
					<td style="border:1px solid">-</td>
				</tr>
			</tbody></table>
			<p style="margin-top:5.5pt;margin-bottom:5.5pt"><span lang="zh-TW" style="font-size:16pt;color:black;font-weight:bold">TG 控制目標</span><span lang="zh-TW" style="font-size:16pt;color:black">：ESC/EAS 指南建議將 TG 水平控制在 &lt; 150 mg/dL，特別是對於高風險患者。</span></p>
			<p style="margin-top:0pt;margin-bottom:0pt"><span lang="zh-TW" style="font-size:16pt;color:#c00000">那台灣呢？</span></p>
		</div>
	

</body></html>
</div>
      </div>
    </div>
  </div>
</body>
</html>